Kisspeptin and the HPG axis: the signal that starts the cascade

Every hormone downstream depends on a conversation that starts in the hypothalamus. GnRH pulses leave the brain, LH and FSH leave the pituitary, testosterone and estradiol leave the gonads. Break the first link and nothing downstream happens. For decades nobody knew what flipped that first link on. Then two papers, two years apart, answered it from opposite directions.

The genetics came first

In 2003, Seminara and colleagues studied a family in which several members never went through puberty, a condition called idiopathic hypogonadotropic hypogonadism. The affected members carried mutations in GPR54, a receptor gene, and cell experiments showed the mutant receptors barely signalled. Mice engineered without the receptor told the same story. The conclusion was blunt: without this receptor, the reproductive axis never starts.

GPR54 turned out to be the receptor for kisspeptin, a peptide first noticed in cancer research and named after Hershey’s Kisses (the lab was in Hershey, Pennsylvania). A metastasis suppressor became, almost overnight, the most important molecule in reproductive endocrinology.

Then the infusions confirmed it in people

Genetics says what happens when the signal is missing. Dhillo’s group asked the reverse: what happens when you add it. In 2005 they infused kisspeptin-54 into healthy men and measured the axis response directly. LH roughly doubled against saline, FSH rose, and testosterone followed. They also measured the pharmacokinetics properly: a half-life under half an hour, about 27 minutes, which is why kisspeptin is a signalling event, not a background level. Pulses, not presence.

That short half-life matters for anyone reading this literature. Kisspeptin is how the brain talks in bursts. A compound that mimics a burst is a different research tool from one that raises a baseline, and studies that ignore the distinction produce noise.

Where the field stands now

A 2026 review in Reviews in Endocrine and Metabolic Disorders retraced the whole circuit, from kisspeptin neurons through metabolic inputs like leptin, and the picture is richer but not simpler: kisspeptin neurons integrate energy status, stress, and circadian signals before telling GnRH neurons to fire. Which explains observations athletes have made forever, that heavy energy deficit shuts down the reproductive axis, now with a named set of neurons in the middle.

What the data do not show: a therapeutic protocol. Kisspeptin infusion is an experimental manipulation with minutes-long kinetics, studied in controlled settings, not a treatment with established regimens or long-term human data. The genetics proves necessity. The infusions prove acute effect. Everything between those two facts and a clinical application is still being worked out.

One catalogue note for researchers: PRIMALFORM does not list a kisspeptin preparation. The linked product is clomiphene, which acts on the same HPG axis from the opposite end, at estrogen feedback rather than at the hypothalamic trigger. Different lever, same machine. Match the preparation to the question.

Research use only. This page summarises published genetics and human infusion literature. It is not medical advice, not a suggestion for human use, and not a protocol. Nothing we supply is for human or veterinary use.